| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Mar―14 |
RETROSPECTIVE COHORT STUDY TO EVALUATE THE CLINICAL EFFICACY OF REMDESIVIR IN THE TREATMENT OF PATIENTS WITH SEVERE COVID-19 |
O. K. Yakovenko |
| 2 |
[GO] |
2023―Dec―19 |
CARDIOVASCULAR SYSTEM STATUS IN PATIENTS WITH DYSPNEA AFTER COVID-19-ASSOCIATED PNEUMONIA |
L. I. Konopkina, O. O. Shchudro |
| 3 |
[GO] |
2023―Sep―26 |
CLINICAL EFFICACY AND SAFETY OF AMINOCAPROIC ACID IN THE TREATMENT OF PATIENTS WITH MILD COVID-19 AND THE PRESENCE OF RISK FACTORS FOR DISEASE PROGRESSION |
O. K. Yakovenko, O.Y. Dziublyk, G.B. Kapitan, Y.O. Dziublyk, V. A. Yachnyk |
| 4 |
[GO] |
2023―Sep―26 |
IMPACT OF COVID-19 ON THE COURSE OF ASTHMA IN CHILDREN |
O. O. Rechkina, S. M. Rudenko, O. M. Kravtsova |
| 5 |
[GO] |
2023―Jun―30 |
SURGICAL TREATMENT OF RARE PULMONARY COMPLICATIONS CAUSED BY COVID-19: A CLINICAL CASE OF GIANT FALSE LUNG CYST COMPLICATED WITH HEMATOMA |
M. S. Opanasenko, B.M. Konik, O. V. Tereshkovych, S. M. Shalagay, A. M. Stepaniuk, L. I. Levanda, et al. (+5) M. I. Kalenychenko, V. I. Lysenko, M. Yu. Shamray, S. M. Bilokon, O. D. Shestakova |
| 6 |
[GO] |
2023―Jun―30 |
THE RISK FACTORS FOR THROMBOSIS IN PATIENTS RECOVERED AFTER COMMUNITY ACQUIRED PNEUMONIA ASSOCIATED WITH COVID-19 |
T. O. Pertseva, N. O. Gabshidze |
| 7 |
[GO] |
2023―Jun―30 |
COVID-19-ASSOCIATED CHANGES IN IMMUNITY AND LUNG LESIONS |
О. M. Rekalova |
| 8 |
[GO] |
2023―Jun―30 |
BARRIERS IN ACHIEVING ASTHMA CONTROL IN CLINICAL PRACTICE DURING THE COVID-19 PANDEMIC |
Y. I. Feshchenko, M. O. Polianska, S. G. Opimakh, S. M. Moskalenko, I. V. Zvol |
| 9 |
[GO] |
2023―Jun―30 |
APPLICATION OF THE OZONE THERAPY IN COMPLEX PROGRAM OF REHABILITATION OF PATIENTS WITH COMMUNITY-ACQUIRED POLYSEGMENTAL PNEUMONIA ASSOCIATED WITH SARS-COV-2 VIRUS (CLINICAL CASE) |
І. А. Iliuk, I. V. Baranova, K. P. Postovitenko, S. V. Shevchuk, I. V. Kurilenko, N. V. Popenko |
| 10 |
[GO] |
2023―Apr―19 |
SEVERE COVID-19: A CROSS-SECTION REVIEW OF DATA FROM FIRST TWO YEARS OF PANDEMIC |
O. K. Yakovenko, L. M. Dzhumaniuk, O. G. Hanin |
| 11 |
[GO] |
2022―Dec―22 |
CLINICAL AND LABORATORY FEATURES OF CORONAVIRUS DISEASE AND RISK FACTORS OF LETHAL OUTCOME IN PATIENTS WHO REQUIRED HOSPITALIZATION DURING THE THIRD WAVE OF COVID-19 IN UKRAINE: A SINGLE-CENTER RETROSPECTIVE STUDY |
Т. О. Pertseva, K. Y. Gashynova, V. V. Rudakova, V. V. Rodionova, V. V. Dmytrychenko, O. Y. Kovalenko, et al. (+6) O. V. Kravets, N. O. But, N. V. Laksha, L. A. Hlyniana, O. F. Mykhailenko, S. P. Novikov |
| 12 |
[GO] |
2022―Jul―14 |
LABORATORY DIAGNOSTIC ALGORITHMS FOR COVID-19 |
I. V. Dziublyk, O. L. Bororova, G. B. Kapitan, O. K. Yakovenko |
| 13 |
[GO] |
2022―Jul―14 |
ASPECTS OF CORONAVIRUS INFECTION PATHOGENESIS AND PROGNOSIS FOR PATHOMORPHOSIS OF PULMONARY TUBERCULOSIS DURING THE COVID-19 PANDEMIC |
L. D. Todoriko, Y. I. Feshchenko, I. O. Semianiv, M. M. Kuzhko, O. S. Shevchenko, R. L. Lyubevych |
| 14 |
[GO] |
2022―Jul―14 |
LONG-TERM TREATMENT OUTCOMES IN COMMUNITY-ACQUIRED COVID-19 VIRAL PNEUMONIA ASSESSED BY COMPUTED TOMOGRAPHY DATA |
O. K. Yakovenk, V. I. Ignatieva, G. L. Gumeniuk, O. R. Tarasenko, V. A. Svyatnenko, M. I. Lynnyk |
| 15 |
[GO] |
2021―Dec―23 |
PECULIARITIES OF CLINICAL MANAGEMENT OF ASTHMA DURING CORONAVIRUS DISEASE (COVID-19) PANDEMIC |
L. I. Konopkina |
| 16 |
[GO] |
2021―Dec―23 |
ANTIVIRAL ACTIVITY OF AMINOCAPROIC ACID AGAINST INFECTIOUS BRONCHITIS CORONAVIRUS IN VITRO |
I. V. Dziublyk, O. P. Trokhimenko, S. O. Soloviov, G. L. Gumeniuk, O. Ya. Dziublyk, N. I. Gumeniuk, O. K. Yakovenko |
| 17 |
[GO] |
2021―Oct―18 |
MODERN ASPECTS OF PULMONARY REHABILITATION IN THE CONTEXT OF THE COVID-19 PANDEMIC |
І. А. Iliuk, K. P. Postovitenko, I. V. Baranova, S. I. Leshchenko, S. V. Shevchuk, L. P. Denyshchych, et al. (+2) I. V. Kurilenko, N. M. Prykhodko |
| 18 |
[GO] |
2021―Oct―18 |
THE CASE OF COVID-19 WITH ATYPICAL PULMONARY LESIONS AND A LIFETIME HISTOLOGICAL EXAMINATION |
О. M. Rekalova, I. V. Liskina, E. M. Maetnyi, M. I. Kulyk |
| 19 |
[GO] |
2021―Oct―18 |
THORACIC SURGICAL TREATMENT IN PATIENTS WITH CORONAVIRUS INFECTION |
M. S. Opanasenko, B. M. Konik, S. M. Belokon, O. V. Tereshkovich, S. M. Shalagai, L. I. Levanda, et al. (+5) M. I. Kalinichenko, V. I. Lysenko, M. U. Shamrai, A. M. Stepanyuk, O. D. Shestakova |
| 20 |
[GO] |
2021―Jul―13 |
ACUTE RESPIRATORY DISEASE COVID-19 AS OCCUPATIONAL DISEASE |
A. V. Basanets, O. V. Yermakova, L. B. Kriukova, V. A. Gvozdetsky, N. V. Zhurahovskaya |
| 21 |
[GO] |
2021―Jul―13 |
CLINICAL FEATURES OF SEVERE COVID-19 WITH LETHAL OUTCOME IN VOLYN REGION RESIDENTS |
O. K. Yakovenko, O. G. Khanin, V. V. Lotysh, S. L. Gryf |
| 22 |
[GO] |
2021―Apr―13 |
PULMONARY DISEASE IN COVID-19 |
Y. I. Feshchenko, O. A. Golubovska, A. Y. Dziublyk, V. K. Gavrysyuk, Y. A. Dziublyk, I. V. Liskina |
| 23 |
[GO] |
2021―Apr―13 |
EXPEDIENCY AND SAFETY OF NEBULIZER THERAPY IN PATIENTS WITH INFECTIOUS DISEASES OF THE RESPIRATORY TRACT DURING COVID-19 PANDEMIC |
Y. O. Dziublyk, O. L. Bororova, Y. O. Patiuk |
| 24 |
[GO] |
2021―Apr―13 |
POSSIBILITIES TO IMPROVE ASTHMA CONTROL DURING THE COVID-19 PANDEMIC |
S. V. Zaikov |
| 25 |
[GO] |
2021―Apr―13 |
ASTHMA DURING COVID-19 PANDEMIC: SMART-THERAPY FOR ASTHMA CONTROL AND PREVENTION OF EXACERBATIONS |
M. M. Ostrovsky |
| 26 |
[GO] |
2020―Dec―17 |
COVID-19 ASSOCIATED COMMUNITY-ACQUIRED PNEUMONIA: CLINICAL EXPERIENCE OF PARENTERAL USE OF ACETYLCYSTEINE IN COMPLEX THERAPY |
Y. O. Dziublyk, L. V. Panchenko |
| 27 |
[GO] |
2020―Dec―17 |
MANAGEMENT OF COPD PATIENTS IN A COVID-19 PANDEMIC |
A. Y. Dziublyk |
| 28 |
[GO] |
2020―Dec―17 |
COMMUNITY-ACQUIRED PNEUMONIA AND COVID-19: DISCUSSION ISSUES |
Y. O. Dziublyk |
| 29 |
[GO] |
2020―Dec―17 |
COPD AND COVID-19: HOW TO PROTECT THE PATIENT? |
M. M. Ostrovsky |
| 30 |
[GO] |
2020―Dec―17 |
CT-SEMIOTICS OF LUNG INVOLVEMENT IN COPD AND CORONAVIRUS DISEASE-2019 |
V. K. Gavrysyuk |
| 31 |
[GO] |
2020―Jul―08 |
CT-SEMIOTICS OF PULMONARY LESIONS IN CORONAVIRUS DISEASE (COVID-19) |
V. K. Gavrysyuk |
| 32 |
[GO] |
2020―Jul―08 |
OUR EXPERIENCE WITH NON-INVASIVE VENTILATION (NIV) IN PATIENTS WITH COVID-19 |
C. N. Pashaev, R. Sh. Polukhov, E. M. Nasibova, M. M. Abasov, R. B. Yelchiev, E.R. Guliev, et al. (+6) F.M. Mustafayev, J. Nabiev, A.M. Gurbanova, A.F. Elchizade, I.T. Aliev, F.M. Gazieva |
| 33 |
[GO] |
2020―Jul―08 |
COMMUNITY-ACQUIRED PNEUMONIA ASSOCIATED WITH COVID-19: THE TREATMENT PERSPECTIVES |
Y. I. Feshchenko, O. Y. Dziublyk, Y. O. Dziublyk, M. M. Pylypenko, O. L. Bororova |
| 34 |
[GO] |
2020―Jul―08 |
THE VIRUCIDAL EFFECT OF DECAMETHOXIN IN VITRO AGAINST CORONAVIRUS OF INFECTIOUS BRONCHITIS |
O. Ya. Dziublyk, I. V. Dzyublyk, O. P. Trokhimenko, O. L. Bororova |
